ArticleFrontiers in neurology2022

Alterations of the miR-126-3p/POU2AF1/Spi-B Axis and JCPyV Reactivation in Multiple Sclerosis Patients Receiving Natalizumab.

Roberta Mancuso et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.